Sage Therapeutics to Participate in SVB Leerink’s 3rd Annual CNS Forum
June 24 2021 - 6:30AM
Business Wire
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical
company committed to developing novel therapies with the potential
to transform the lives of people with debilitating disorders of the
brain, today announced that the Company will participate in a
fireside chat at SVB Leerink’s 3rd Annual CNS Forum on June 29th at
4:15pm ET.
A live webcast of each presentation can be accessed on the
investor page of Sage's website at investor.sagerx.com. A replay of
the webcasts will be available approximately two hours after the
completion of the event and will be archived for up to 30 days.
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company committed to
developing novel therapies with the potential to transform the
lives of people with debilitating disorders of the brain. We are
pursuing new pathways with the goal of improving brain health, and
our depression, neurology and neuropsychiatry franchise programs
aim to change how brain disorders are thought about and treated.
Our mission is to make medicines that matter so people can get
better, sooner. For more information, please visit
www.sagerx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210624005173/en/
Investor Contact Jeff Boyle 617-949-4256
Jeff.Boyle@sagerx.com Media Contact Maureen L. Suda
617-949-4289 maureen.suda@sagerx.com
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Oct 2023 to Oct 2024